High blood pressure stands among the leading causes of stroke, yet many people fail to recognize the critical importance of ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

Many treatments exist to minimize the effects of cardiovascular disease on quality of life and longevity but, an ounce of ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

When using high-flow nasal cannula (HFNC), setting a higher flow rate of 60 vs 40 L/min for post-extubation care did not improve key outcomes.

A recent study published in the journal eLife has revealed significant links between blood types and the risk of developing ...

Surmodics (Nasdaq:SRDX) today announced the successful early clinical use of its Pounce XL thrombectomy system.

After years of decreasing amputations in the United States, rates of non-traumatic lower extremity amputations due to ...

Early findings suggest that IA tenecteplase after successful thrombectomy is safe and improves functional outcomes over standard care in anterior circulation LVO stroke.

The burden of cardiovascular diseases among smokers is profoundly evident. Cigarette smoking, a leading preventable cause of morbidity and mortality, exerts a particularly pernicious impact on the ...